-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
C4 Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q3 2019 to Q3 2024.
- C4 Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.35 USD/shares, a 36.4% increase year-over-year.
- C4 Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -1.7 USD/shares, a 38.2% increase year-over-year.
- C4 Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -2.67 USD/shares, a 1.91% decline from 2022.
- C4 Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -2.62 USD/shares, a 44% decline from 2021.
- C4 Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -1.82 USD/shares, a 68.8% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)